ForSight Vision5 lands $15M Series C round
April 18, 2014 by Brad Perriello
ForSight Vision5, which is developing devices to treat front-of-the-eye conditions such as glaucoma and dry eye disease, said it pulled down a $15 million Series C round.
ForSight Vision5 is a spinout of ForSight Labs, a Menlo Park, Calif.-based incubator focused on developing ophthalmic treatments. Read more
GE gets behind Cerapedics and its i-FACTOR bone graft
April 21, 2014 by Arezu Sarvestani
Tech and healthcare giant GE put some skin in Cerapedics and its i-FACTOR bone graft, funding a $9 million venture debt financing round for the Colorado-based company.
Cerapedics plans to use the funds to make progress toward the U.S market and to support “general business operations,” the company said this month. Read more
Report: Medtech VC deals down, values up in Q1
April 21, 2014 by Brad Perriello
Venture capitalists put more skin in fewer deals during the 1st quarter, amid an overall decline in life science deals, according to a survey of VC shops.
The number of deals for the medical device & equipment sector dropped 37% to 61 transactions, but the total value of those deals rose 28% to $588 million, according to the MoneyTree report from PricewaterhouseCoopers LLP and the National Venture Capital Assn., based on data provided by Thomson Reuters. Read more
Sotera aims for $54M for continuous patient monitoring
April 23, 2014 by Arezu Sarvestani
California-based Sotera Wireless is looking to raise $53.9 million in an ongoing funding round, with about $20.7 million raised as of Monday, regulatory filings show.
The patient monitoring systems maker is offering equity, rights and securities, with 23 unnamed investors listed so far. The total offering amount includes about $2.3 million in securities issued on conversion of indebtedness as well as nearly $3.7 million in un-exercised warrants for preferred stock, according to the SEC filing. Read more
Spine: Baxano Surgical closes $10M private placement
April 24, 2014 by Arezu Sarvestani
Baxano Surgical Inc. offered few details about its latest private placement funding round, saying only that it raised $10 million from “entities affiliated with two institutional investors.”
The spinal surgery devices maker had announced the funding agreement last month, saying that it would offer subordinated convertible debentures and warrants to purchase more than 9.4 million shares of common stock as long as its shareholders approved the transaction. Read more
